Source: Annual Congress 2007 - The air we breathe at home and at work
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Murgia, M. dell‘Omo, G. Brugnami, B. Marta, G. Muzi, G. Abbritti (Perugia, Italy). Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study. Eur Respir J 2007; 30: Suppl. 51, 4440

Member's Comments

No comment yet.

Related content which might interest you: Rare pneumoconioses Source: Annual Congress 2005 - Update on orphan lung diseases Year: 2005 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Interstitial lung diseases in childhood Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213 Year: 2002 Retrospective studies of the association between idiopathic pulmonary fibrosis and lifestyle-related disease Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007 Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005 The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Genetic susceptibility and pulmonary fibrosis Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management Year: 2005 Rare interstitial lung diseases of environmental origin Source: Eur Respir Mon 2011; 54: 301-316 Year: 2011 Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Source: Eur Respir Rev 2012 21: 355-361 Year: 2012 Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Source: Eur Respir J 2010; 35: 105-111 Year: 2010 Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013